BACKGROUND: Rotavirus is a leading cause of childhood morbidity and mortality
worldwide. Clinical trials for two rotavirus vaccines recommended by the WHO for global use …

Background Mozambique introduced rotavirus vaccine (Rotarix, GSK Biologicals) in the
National Immunization Program in September 2015 with the objective of reducing the …

Introduction Rotavirus vaccines protect against the leading cause of severe childhood
diarrhoea, and have been introduced in many low-income African countries. The Gambia …

Background. Rotavirus vaccine is recommended for routine use in all countries globally. To
facilitate decision making on rotavirus vaccine adoption by countries, help donors prioritize …

Introduction Rotavirus infection accounts for 39% of under-five diarrhoeal deaths globally
and 22% of these deaths occur in India. Introduction of rotavirus vaccine in a national …

Background Rotavirus has a significant morbidity and mortality in children under two years.
The burden of rotavirus diarrhea 4 years post introduction of rotavirus vaccine in Uganda is …

Background Following the conclusion of a human rotavirus vaccine (HRV) cluster-
randomized, controlled trial (CRT) in Matlab, Bangladesh, HRV was included in Matlab's …

Introduction Diarrhoea remains a leading cause of child morbidity and mortality.
Systematically collected and analysed data on the aetiology of hospitalised diarrhoea in low …

Background Monovalent rotavirus vaccine (RV1) was introduced in the immunization
schedule of Togo in June 2014. We evaluated the impact of rotavirus vaccines on acute …

Background. Mexico implemented routine childhood vaccination against rotavirus in 2007.
We describe trends in hospitalization and deaths from diarrhea among children aged< 5 …